Glen Santangelo
Stock Analyst at Jefferies
(2.96)
# 2,567
Out of 4,843 analysts
76
Total ratings
44.68%
Success rate
0.12%
Average return
Main Sectors:
Stocks Rated by Glen Santangelo
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TDOC Teladoc Health | Maintains: Hold | $10 → $8 | $6.92 | +15.61% | 7 | Apr 21, 2025 | |
| ANIP ANI Pharmaceuticals | Initiates: Buy | $80 | $58.72 | +36.24% | 1 | Mar 14, 2025 | |
| VTRS Viatris | Maintains: Buy | $15 → $13 | $8.79 | +47.90% | 4 | Mar 7, 2025 | |
| WAY Waystar Holding | Initiates: Buy | $51 | $39.98 | +27.56% | 1 | Feb 11, 2025 | |
| XERS Xeris Biopharma Holdings | Reiterates: Buy | $4 → $6 | $4.94 | +21.46% | 2 | Jan 29, 2025 | |
| NVST Envista Holdings | Maintains: Hold | $20 → $22 | $18.27 | +20.42% | 1 | Jan 23, 2025 | |
| XRAY DENTSPLY SIRONA | Downgrades: Hold | $30 → $20 | $15.98 | +25.16% | 2 | Jan 23, 2025 | |
| PCRX Pacira BioSciences | Maintains: Buy | $15 → $18 | $25.84 | -30.34% | 5 | Sep 24, 2024 | |
| PGNY Progyny | Maintains: Buy | $31 → $24 | $21.50 | +11.63% | 4 | Sep 19, 2024 | |
| HIMS Hims & Hers Health | Maintains: Hold | $14 → $23 | $56.56 | -59.34% | 4 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $23 | $16.78 | +37.07% | 4 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $41 → $44 | $29.14 | +51.00% | 3 | Jun 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $17 | $13.44 | +26.49% | 1 | Dec 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $230 | $168.63 | +36.39% | 1 | Dec 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $0.49 | +1,921.84% | 2 | Dec 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $70 | $25.71 | +172.27% | 2 | Jul 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $55 | $7.21 | +662.83% | 1 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $4.25 | +276.47% | 1 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $14 | $3.64 | +284.62% | 1 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $78 → $46 | $52.09 | -11.69% | 2 | May 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $62 → $80 | $100.61 | -20.49% | 2 | Mar 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $31 → $28 | $3.80 | +636.84% | 2 | Mar 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $70 | $24.49 | +185.83% | 1 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $120 | $6.74 | +1,680.42% | 3 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $2 | $3.19 | -37.30% | 1 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $47 | $3.92 | +1,098.98% | 1 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $36 | $3.31 | +987.61% | 1 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $64.04 | - | 3 | Mar 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $173 → $169 | $719.51 | -76.51% | 5 | May 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $154.44 | - | 4 | Dec 16, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $79 → $82 | $69.99 | +17.16% | 2 | Apr 24, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $250 | $180.94 | +38.17% | 1 | Dec 8, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $78 | $11.25 | +593.33% | 1 | Dec 4, 2017 |
Teladoc Health
Apr 21, 2025
Maintains: Hold
Price Target: $10 → $8
Current: $6.92
Upside: +15.61%
ANI Pharmaceuticals
Mar 14, 2025
Initiates: Buy
Price Target: $80
Current: $58.72
Upside: +36.24%
Viatris
Mar 7, 2025
Maintains: Buy
Price Target: $15 → $13
Current: $8.79
Upside: +47.90%
Waystar Holding
Feb 11, 2025
Initiates: Buy
Price Target: $51
Current: $39.98
Upside: +27.56%
Xeris Biopharma Holdings
Jan 29, 2025
Reiterates: Buy
Price Target: $4 → $6
Current: $4.94
Upside: +21.46%
Envista Holdings
Jan 23, 2025
Maintains: Hold
Price Target: $20 → $22
Current: $18.27
Upside: +20.42%
DENTSPLY SIRONA
Jan 23, 2025
Downgrades: Hold
Price Target: $30 → $20
Current: $15.98
Upside: +25.16%
Pacira BioSciences
Sep 24, 2024
Maintains: Buy
Price Target: $15 → $18
Current: $25.84
Upside: -30.34%
Progyny
Sep 19, 2024
Maintains: Buy
Price Target: $31 → $24
Current: $21.50
Upside: +11.63%
Hims & Hers Health
Jun 27, 2024
Maintains: Hold
Price Target: $14 → $23
Current: $56.56
Upside: -59.34%
Jun 27, 2024
Maintains: Buy
Price Target: $19 → $23
Current: $16.78
Upside: +37.07%
Jun 7, 2024
Upgrades: Buy
Price Target: $41 → $44
Current: $29.14
Upside: +51.00%
Dec 19, 2023
Initiates: Buy
Price Target: $17
Current: $13.44
Upside: +26.49%
Dec 19, 2023
Assumes: Buy
Price Target: $230
Current: $168.63
Upside: +36.39%
Dec 15, 2023
Reiterates: Buy
Price Target: $10
Current: $0.49
Upside: +1,921.84%
Jul 25, 2023
Reinstates: Buy
Price Target: $70
Current: $25.71
Upside: +172.27%
Oct 21, 2022
Initiates: Hold
Price Target: $55
Current: $7.21
Upside: +662.83%
Oct 21, 2022
Initiates: Buy
Price Target: $16
Current: $4.25
Upside: +276.47%
Oct 21, 2022
Assumes: Buy
Price Target: $14
Current: $3.64
Upside: +284.62%
May 18, 2022
Maintains: Buy
Price Target: $78 → $46
Current: $52.09
Upside: -11.69%
Mar 28, 2022
Maintains: Buy
Price Target: $62 → $80
Current: $100.61
Upside: -20.49%
Mar 17, 2022
Upgrades: Buy
Price Target: $31 → $28
Current: $3.80
Upside: +636.84%
Dec 2, 2021
Initiates: Buy
Price Target: $70
Current: $24.49
Upside: +185.83%
Dec 2, 2021
Initiates: Hold
Price Target: $120
Current: $6.74
Upside: +1,680.42%
Dec 2, 2021
Initiates: Hold
Price Target: $2
Current: $3.19
Upside: -37.30%
Dec 2, 2021
Initiates: Buy
Price Target: $47
Current: $3.92
Upside: +1,098.98%
Dec 2, 2021
Initiates: Buy
Price Target: $36
Current: $3.31
Upside: +987.61%
Mar 17, 2021
Downgrades: Neutral
Price Target: n/a
Current: $64.04
Upside: -
May 21, 2020
Maintains: Hold
Price Target: $173 → $169
Current: $719.51
Upside: -76.51%
Dec 16, 2019
Downgrades: Neutral
Price Target: n/a
Current: $154.44
Upside: -
Apr 24, 2018
Maintains: Buy
Price Target: $79 → $82
Current: $69.99
Upside: +17.16%
Dec 8, 2017
Initiates: Hold
Price Target: $250
Current: $180.94
Upside: +38.17%
Dec 4, 2017
Initiates: Hold
Price Target: $78
Current: $11.25
Upside: +593.33%